Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor |
| |
Authors: | Varela-Rohena Angel Molloy Peter E Dunn Steven M Li Yi Suhoski Megan M Carroll Richard G Milicic Anita Mahon Tara Sutton Deborah H Laugel Bruno Moysey Ruth Cameron Brian J Vuidepot Annelise Purbhoo Marco A Cole David K Phillips Rodney E June Carl H Jakobsen Bent K Sewell Andrew K Riley James L |
| |
Institution: | Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA. |
| |
Abstract: | HIV's considerable capacity to vary its HLA-I-restricted peptide antigens allows it to escape from host cytotoxic T lymphocytes (CTLs). Nevertheless, therapeutics able to target HLA-I-associated antigens, with specificity for the spectrum of preferred CTL escape mutants, could prove effective. Here we use phage display to isolate and enhance a T-cell antigen receptor (TCR) originating from a CTL line derived from an infected person and specific for the immunodominant HLA-A(*)02-restricted, HIVgag-specific peptide SLYNTVATL (SL9). High-affinity (K(D) < 400 pM) TCRs were produced that bound with a half-life in excess of 2.5 h, retained specificity, targeted HIV-infected cells and recognized all common escape variants of this epitope. CD8 T cells transduced with this supraphysiologic TCR produced a greater range of soluble factors and more interleukin-2 than those transduced with natural SL9-specific TCR, and they effectively controlled wild-type and mutant strains of HIV at effector-to-target ratios that could be achieved by T-cell therapy. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|